Respiratory News and Research

RSS

Updated guidelines released for treatment of idiopathic pulmonary fibrosis

Updated guidelines on the treatment of idiopathic pulmonary fibrosis (IPF) have been released by an international group of leading respiratory societies, The new guidelines, issued by the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association, were published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

15 Jul 2015

New study highlights burden of community-acquired pneumonia hospitalizations among U.S. adults

Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center.

15 Jul 2015

Teen birth, mental illness increase hospitalization of children in Texas

From 2004 to 2010 in Texas, mental illness was the most common reason for the hospitalization of children ages 10-14 while pregnancy/birth was the most common reason for the hospitalization of adolescents ages 15-17, according to researchers at The University of Texas Health Science Center at Houston Medical School.

15 Jul 2015

New study reveals highly promising approach to coating tissue engineered constructs

A new study showing the ability to apply a thin coating of viable respiratory epithelial cells to tissue engineered constructs using a commercially available spray device is especially promising for therapeutic approaches in development to repair or replace challenging structures such as trachea or bronchi.

15 Jul 2015

Study shows possibility of using embryonic stem cells to repair damaged lung tissue

Collectively, such diseases of the airways as emphysema, bronchitis, asthma and cystic fibrosis are the second leading cause of death worldwide. More than 35 million Americans alone suffer from chronic respiratory disease. Weizmann Institute scientists have now proposed a new direction that could, in the future, lead to the development of a method for alleviating some of their suffering.

15 Jul 2015

Innovation in anaesthesia: an interview with Matti Lehtonen, GE Healthcare

The spectrum of patients seen today, from pre-term infants to the morbidly obese to the longer living elderly, is wider than ever before and increasingly more challenging with patients often presenting with multiple co-morbidities. This puts a huge strain on healthcare providers who are facing increasing challenges such as cost pressure and staff shortages.

14 Jul 2015

Accuray announces presentation of CyberKnife System data at AAPM annual meeting

Accuray Incorporated announced today that studies on the clinical use of the CyberKnife System, the only robotic SBRT system capable of tracking and automatically correcting for target motion, continue to demonstrate the benefits of its precise, innovative treatment delivery techniques.

14 Jul 2015

KF-SYSCC creates paperless, filmless clinical process in radiation oncology to enhance patient safety

The Koo Foundation Sun Yat-Sen Cancer Center has established an entirely paperless and filmless clinical process in radiation oncology, designed to enhance patient safety as well as operational efficiency. Using the ARIA oncology information system from Varian Medical Systems, the clinical team has automated essential tasks, built in safety-checks, and centralized patient information for easier access by staff members.

13 Jul 2015

COPD risk may occur during childhood and adolescence

Chronic obstructive pulmonary disease (COPD) is one of most common causes of death in the world today - active smoking accounting for approx. 85% of all cases. Yet ground-breaking research from the University of Copenhagen indicates that accelerated decline of lung function is not a prerequisite for COPD.

13 Jul 2015

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

Today AbbVie announced the European Commission granted marketing authorization for IMBRUVICA (ibrutinib) as the first treatment option available in all 28 member states of the European Union for the treatment of Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer, in adult patients who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.

12 Jul 2015

WellStar opens new inpatient pediatric unit

WellStar Kennestone Hospital opened a new inpatient pediatric unit. Previously, Cobb County did not have an inpatient pediatric unit, forcing families to leave their community to receive hospital-based care. The new unit will keep pediatric patients and their families close to home.

12 Jul 2015

Researchers reveal how certain lipids help adenoviruses to enter the cell

Adenoviruses cause numerous diseases, such as eye or respiratory infections, and they are widely used in gene therapy. Researchers from the University of Zurich have now discovered how these viruses penetrate the cells, a key step for infection and gene delivery. The cell unwillingly supports virus entry and infection by providing lipids that are normally used to repair damaged membranes.

10 Jul 2015

Starting anti-HIV treatment early improves survival among patients with newly diagnosed TB

Starting anti-HIV treatment within two weeks of the diagnosis of tuberculosis, or TB, improved survival among patients with both infections who had very low immune-cell counts, according to an analysis by researchers at the University of Pittsburgh Graduate School of Health.

10 Jul 2015

Tillotts Pharma to purchase global rights for AstraZeneca’s Entocort excluding the U.S.

Tillotts Pharma AG, part of the Zeria Group, announced today that it has entered into an agreement for the acquisition of the global rights for Entocort (budesonide) from AstraZeneca, excluding the U.S., which will remain with AstraZeneca.

9 Jul 2015

EvoRx Technologies, AstraZeneca successfully complete research collaboration

AstraZeneca and EvoRx Technologies successfully completed a one-year research collaboration leveraging EvoRx's proprietary Evo-Link technology to discover cell penetrating peptides for a high value intracellular protein–protein interaction target in the respiratory portfolio.

9 Jul 2015

New nanometer catalyst filter removes 100% of particle substances of cigarette smoke

The research team led by Dr. Jongsoo Jurng and Dr. Gwi-Nam at KIST stated that, "In cooperation with KT&G, KIST has developed a nano-catalyst filter coated with a manganese oxide-based nano-catalyst, which can be used in a smoking room to reduce and purify major harmful substances of cigarette smoke.

9 Jul 2015

Adolescents more likely to try e-cigarettes when exposed to TV ads

Adolescents who are exposed to e-cigarette TV advertising are more likely to try e-cigarettes in the future, according to a groundbreaking experiment from researchers at RTI International. Although advertising and adolescent use of e-cigarettes have simultaneously increased in recent years, this is the first study to demonstrate a direct link between adolescents' exposure to advertising and their likelihood of future use.

8 Jul 2015

Sepsis readmissions have significant impact on health care expenditures in California

The Affordable Care Act created several national initiatives aimed at reducing hospital readmission rates for heart attacks, congestive heart failure and other common high-risk conditions. But there is still no national program intended to address sepsis, a potentially life-threatening illness caused by infection.

8 Jul 2015

Findings reveal new pathway to develop effective treatments and therapies for asthma, allergy

Investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body. The findings from Weill Cornell Medical College reveal a new pathway that scientists could use to develop more effective treatments and therapies for the chronic lung disorder.

7 Jul 2015

New portable system can produce life-saving NO from air by means of electrical spark

Treatment with inhaled nitric oxide (NO) has proven to be life saving in newborns, children and adults with several dangerous conditions, but the availability of the treatment has been limited by the size, weight and complexity of equipment needed to administer the gas and the therapy's high price.

7 Jul 2015

Respiratory News and Research

Updated guidelines released for treatment of idiopathic pulmonary fibrosis

New study highlights burden of community-acquired pneumonia hospitalizations among U.S. adults

Teen birth, mental illness increase hospitalization of children in Texas

New study reveals highly promising approach to coating tissue engineered constructs

Study shows possibility of using embryonic stem cells to repair damaged lung tissue

Innovation in anaesthesia: an interview with Matti Lehtonen, GE Healthcare

Accuray announces presentation of CyberKnife System data at AAPM annual meeting

KF-SYSCC creates paperless, filmless clinical process in radiation oncology to enhance patient safety

COPD risk may occur during childhood and adolescence

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

WellStar opens new inpatient pediatric unit

Researchers reveal how certain lipids help adenoviruses to enter the cell

Starting anti-HIV treatment early improves survival among patients with newly diagnosed TB

Tillotts Pharma to purchase global rights for AstraZeneca’s Entocort excluding the U.S.

EvoRx Technologies, AstraZeneca successfully complete research collaboration

New nanometer catalyst filter removes 100% of particle substances of cigarette smoke

Adolescents more likely to try e-cigarettes when exposed to TV ads

Sepsis readmissions have significant impact on health care expenditures in California

Findings reveal new pathway to develop effective treatments and therapies for asthma, allergy

New portable system can produce life-saving NO from air by means of electrical spark

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News